Write in a clean editor, then format for Japanese Journal of Cancer Research in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Japanese Journal of Cancer Research is a peer-reviewed journal published by Oxford University Press, covering Cancer-related Molecular Pathways, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Author–year (OUP) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Japanese Journal of Cancer Research, 12(3), pp. 45–58.
Formats any DOI in the closest standard style — Japanese Journal of Cancer Research has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Cancer-related Molecular Pathways Monoclonal and Polyclonal Antibodies Research Immunotherapy and Immune Responses Immune Cell Function and Interaction Cancer therapeutics and mechanisms |
| ISSN | 0910-5050 |
| h-index | 112 |
| i10-index | 2,101 |
| Total citations | 89,047 |
| Top institutions publishing here | National Cancer Research Institute |
| Journal website | www.jca.gr.jp |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The objective of this study was to investigate the molecular weight (MW) and time-dependence of the phenomenon termed "the enhanced permeability and retention" (EPR) effect in solid tumor, in particular to determine and define the early phase accumulation of macromolecules in tumor and normal tissues and the relationship between blood concentration and tissue clearance. As…
Mouse sarcoma 180 or rat ascites hepatoma (AH) 130 cells were exposed to ultrasound (US; 1.27, 2.21 and 3.18 W/cm2; 1.92 MHz) for up to 60 s in vitro in the presence or absence of hematoporphyrin (Hp; 10, 25 and 50 micrograms/ml). The cell-damaging effects of treatments were determined by means of the Trypan Blue…
Angiogenesis is an independent prognostic indicator in breast cancer. In this report, the relationship between expression of vascular endothelial growth factor (VEGF; a selective mitogen for endothelial cells) and the microvessel density was examined in 103 primary breast cancers. The expression of VEGF was evaluated by immunocytochemical staining using anti-VEGF antibody. The microvessel density, which…
Although histone deacetylases (HDACs) appear to play a crucial role in carcinogenesis, the expression status of HDACs in primary human cancer tissues has not yet been reported. In this study, we investigated the expression level of HDAC1 in 25 paired primary human gastric cancer (GC) tissues and corresponding normal tissues through semi-quantitative RT-PCR and immunoblot…
The mechanism of cell damage by ultrasound in combination with hematoporphyrin was studied. Mouse sarcoma 180 cell suspensions were exposed to ultrasound for up to 60 s in the presence and absence of hematoporphyrin, with and without active oxygen scavengers. The cell damage enhancement by hematoporphyrin was suppressed by adding histidine but not by mannitol.…
